Drugplain

eribulin mesylate .5 mg/mL

eribulin mesylate · INJECTION · Apotex Corp.

No Recall History
Plain English

eribulin mesylate is a injection containing eribulin mesylate at .5 mg/mL, taken intravenous. Manufactured by Apotex Corp..

Key Facts

Brand Name
eribulin mesylate
Generic Name
eribulin mesylate
NDC Code (Product)
60505-6435
Manufacturer
Apotex Corp.
Strength
.5 mg/mL
Dosage Form
INJECTION
Route
INTRAVENOUS
Marketing Status
Application #
ANDA218047
Marketing Start
03/19/2025

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

neuropathy peripheral60 reports
malignant neoplasm progression55 reports
pyrexia51 reports
myelosuppression44 reports
fatigue41 reports
off label use40 reports
neutropenia35 reports
nausea34 reports
diarrhoea33 reports
headache30 reports

Frequently Asked Questions

What is eribulin mesylate used for?

eribulin mesylate contains eribulin mesylate. It is a injection taken intravenous. Consult your doctor for specific uses.

Is eribulin mesylate a controlled substance?

eribulin mesylate is not classified as a controlled substance by the DEA.

What is the generic name for eribulin mesylate?

The generic name for eribulin mesylate is eribulin mesylate. There are 10 other brand versions of eribulin mesylate.

What is the NDC code for eribulin mesylate .5 mg/mL?

The NDC (National Drug Code) for eribulin mesylate .5 mg/mL is 60505-6435, listed by Apotex Corp..